Facebook Pixel

The New Eyelash Booster

Rate This

Apparently there really is a cosmetic remedy for everything. This year Allergan, Inc., got the go-ahead from the FDA to launch “Latisse”, a spin-off of the glaucoma drug Lumigan. The prescription medication promotes longer, thicker, darker eyelashes.

The eyelash-boosting power of the drug was discovered when it presented as a side effect in patients using Lumigan eye drops. It didn’t take long before Allergen parlayed the development into a lucrative cosmetic procedure/material that’s now offered by numerous physicians.

Regular use of the drug can cause a darkening of eyelid skin and an increase of pigmentation of the iris. Over a period of months or years brown eyes can become browner.

The idea has been a boon for chemo patients who have lost their eyelashes during treatment.

To learn more about the new eyelash booster log onto:


Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

Eyes & Vision

Get Email Updates

Eyes & Vision Guide

HERWriter Guide

Have a question? We're here to help. Ask the Community.


Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!